InMed Pharmaceuticals Inc - INM Net Assets per Single Share

The high barrier to entry in the psychotropic substance sector is driven by strict regulatory controls and biosynthesis patents. A key book value indicator confirms this specificity, where the value of 0.20 expresses the metric level. InMed Pharmaceuticals (INM) develops high-margin ophthalmological drugs from rare cannabinoids; however, the company currently operates on cash reserves as it has no active commercial sales.

INM (InMed Pharma) Book Value per Share history from 07/04/2022 to 10/27/2026

inmedpharma.com - analytical breakdowns and key metrics (INM)

- price and consensus price forecast:

Price Chart InMed Pharma|INM - Consensus Target

- market capitalization data:

Market Value InMed Pharmaceuticals Inc.|INM - Business Value

- book capitalization data:

Book Value per Share InMed Pharmaceuticals|INM - Book Capitalization|Market Value to Book Value Ratio inmedpharma.com|INM - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital InMed Pharmaceuticals|INM - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity InMed Pharmaceuticals Inc.|INM - Company Cumulative Debt|Debt to Book Value InMed Pharmaceuticals Inc.

Initial company analysis:INM InMed Pharma

Flagship merchandise of InMed Pharmaceuticals Inc.

For InMed Pharmaceuticals (INM), the calculated book value per share reflects the biopharmaceutical business's ability to preserve capital amid high clinical trial costs and regulatory risks. This indicator measures the residual value of net assets per share, allowing investors to assess the company's actual tangible asset base and the protection of capital against cash burn rates.

Competitors of InMed Pharmaceuticals (INM)

INDV: Net Assets per Single Share|COLL: Accounting Value per Share|Net Assets per Single Share Cronos Group Inc.|canopygrowth.com (CGC) - Equity per Share|HITI (High Tide) - Book Value per Share|Book Value per Share ACB|Achieve Life Sciences, Inc (ACHV) - Net Assets per Single Share|Accounting Value of a Share Skye Bioscience Inc. (SKYE)|Anebulo Pharmaceuticals - Book Value per Share|InterCure Ltd - Accounting Value per Share|NTRB (Nutriband Corp) - Net Assets per Single Share|Nasus Pharma Ltd (NSRX) - Net Asset Value per Share|Accounting Value per Share igcinc.us IGC|MIRA Pharmaceuticals, Inc. (MIRA) - Accounting Value of a Share|Book Value per Share Flora Growth Corp. FLGC|Share Book Value IMC|Book Value per Share ADIL|Book Value per Share ARTL (artelobio.com)|Net Assets per Single Share Ensysce Biosciences, Inc.|Titan Pharmaceuticals Inc. - Accounting Value of a Share|GNLN: Net Assets per Single Share|AKAN - Accounting Value per Share|Enveric Biosciences, Inc. - Book Value per Share|BGXX (Bright Green Corporation) - Net Assets per Share|Net Assets per Single Share Hempacco Co., Inc. (HPCO)